Rubella Vaccine (Live) I.P. (Freeze-dried)

Vaccine Overview

The Rubella Vaccine (Live) I.P. (Freeze-dried) is a vaccine used to protect against rubella, a contagious viral infection. It contains live, attenuated rubella virus and is administered via subcutaneous injection, typically in the upper arm. The vaccine is commonly given in combination with measles and mumps vaccines (MMR). The first dose is recommended at 9–12 months, with a second dose at 15–18 months. It helps prevent rubella-related birth defects if administered before pregnancy.

Drug Class: Viral Vaccines

Indication: For active immunization against rubella; For immunization of susceptible non-pregnant females of childbearing age; For immunization of adolescents and adult males for preventing or controlling outbreaks of rubella

PREVENTS

Rubella

Vaccine Details

Applied To

Infants, Children, Adolescents, Adults

Recommended Time

First dose at 9–12 months, second dose at 15–18 months

Administration

Route: Subcutaneous injection

Site: upper outer part of the arm

Disease

Rubella

Manufacturer

Serum Intitute Of India

Age

9-18 months

Disclaimer

This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.

Last updated: May 2, 2025